Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Immunol ; 180(4): 2385-95, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18250448

ABSTRACT

To determine the relationship between influenza A virus replication and innate antiviral immune responses, rhesus monkeys were given oseltamivir before influenza A/Memphis/7/01 (H1N1) challenge. We found that oseltamivir treatment significantly reduced viral replication in the trachea (p < 0.029). Further, in the trachea of both treated and untreated monkeys the mRNA levels of most innate antiviral molecules in the IFN-alphabeta pathway were dramatically increased by 24 h postinfection. However, the mRNA level of a single IFN-stimulated gene, MxA (myxovirus resistance A), the IFN-stimulated gene known to be critical in blocking influenza virus replication, was significantly lower in the tracheal lavages of untreated monkeys than in the oseltamivir-treated monkeys (p = 0.05). These results demonstrate for the first time that uncontrolled influenza A virus replication actively suppresses MxA gene expression and emphasize the critical role of innate immunity in controlling influenza virus replication in vivo.


Subject(s)
GTP-Binding Proteins/antagonists & inhibitors , GTP-Binding Proteins/biosynthesis , Influenza A Virus, H1N1 Subtype/immunology , Interferons/physiology , Orthomyxoviridae Infections/prevention & control , Trachea/metabolism , Trachea/virology , Virus Replication/immunology , Animals , Antibodies, Viral/biosynthesis , Body Temperature , Cell Line , GTP-Binding Proteins/genetics , Humans , Influenza, Human/immunology , Influenza, Human/prevention & control , Influenza, Human/virology , Macaca mulatta , Myxovirus Resistance Proteins , Orthomyxoviridae Infections/immunology , Orthomyxoviridae Infections/virology , RNA, Messenger/biosynthesis , Trachea/immunology
2.
J Acquir Immune Defic Syndr ; 43(1): 6-14, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16810108

ABSTRACT

Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model of pediatric HIV infection to evaluate the potential of chemoprophylactic regimens to reduce mother-to-infant transmission of HIV. Previous studies have demonstrated that short-term subcutaneous administration of the reverse transcriptase inhibitor tenofovir was highly effective in protecting newborn macaques against infection after a single high-dose oral inoculation with virulent SIVmac251. In the current study, we mimicked HIV transmission through breast-feeding by repeatedly feeding infant macaques low doses of SIVmac251. Topical administration of a low dose of the second-generation tenofovir prodrug GS-7340 did not have detectable prophylactic efficacy. Oral administration of tenofovir disoproxil fumarate (DF; 10 mg/kg SID) lowered the infection rate at birth, but had lower efficacy against virus infection at 4 weeks of age, most likely because drug levels became suboptimal relative to those obtained with the current tenofovir DF regimen in humans. These prophylactic results further underscore the relevance of the current tenofovir DF prevention trials in pediatric and adult populations.


Subject(s)
Adenine/analogs & derivatives , Anti-HIV Agents/therapeutic use , Organophosphonates/therapeutic use , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Acquired Immunodeficiency Syndrome/prevention & control , Simian Immunodeficiency Virus/pathogenicity , Adenine/administration & dosage , Adenine/therapeutic use , Administration, Oral , Administration, Topical , Alanine , Animals , Anti-HIV Agents/administration & dosage , Genetic Predisposition to Disease , Macaca mulatta , Organophosphonates/administration & dosage , Prodrugs/administration & dosage , Prodrugs/therapeutic use , Simian Immunodeficiency Virus/drug effects , Tenofovir , Virulence
3.
J Virol ; 80(13): 6357-67, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16775324

ABSTRACT

A vaccine to protect human immunodeficiency virus (HIV)-exposed infants is an important goal in the global fight against the HIV pandemic. Two major challenges in pediatric HIV vaccine design are the competence of the neonatal/infant immune system in comparison to the adult immune system and the frequent exposure to HIV via breast-feeding. Based on the hypothesis that an effective vaccine needs to elicit antiviral immune responses directly at the site of virus entry, the pattern of virus dissemination in relation to host immune responses was determined in mucosal and lymphoid tissues of infant macaques at 1 week after multiple oral exposures to simian immunodeficiency virus (SIV). The results show that SIV disseminates systemically by 1 week. Infant macaques can respond rapidly to virus challenge and mount strong innate immune responses. However, despite systemic infection, these responses are most pronounced in tissues close to the viral entry site, with the tonsil being the primary site of virus replication and induction of immune responses. Thus, distinct anatomic compartments are characterized by unique cytokine gene expression patterns. Importantly, the early response at mucosal entry sites is dominated by the induction of proinflammatory cytokines, while cytokines with direct antiviral activity, alpha/beta interferons, are only minimally induced. In contrast, both antiviral and proinflammatory cytokines are induced in lymphoid tissues. Thus, although infant macaques can respond quickly to oral viral challenge, the locally elicited immune responses at mucosal entry sites are likely to favor immune activation and thereby virus replication and are insufficient to limit virus replication and dissemination.


Subject(s)
HIV Infections/immunology , Immunity, Innate/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/transmission , Simian Immunodeficiency Virus/immunology , Virus Replication/immunology , AIDS Vaccines/immunology , Animals , Animals, Newborn , Breast Feeding , Cytokines/immunology , Disease Outbreaks/prevention & control , HIV Infections/prevention & control , HIV Infections/transmission , Humans , Immunity, Mucosal/immunology , Infant, Newborn , Inflammation/immunology , Inflammation/prevention & control , Inflammation/virology , Macaca mulatta , Mouth Mucosa/immunology , Mouth Mucosa/virology , Palatine Tonsil/immunology , Palatine Tonsil/virology , SAIDS Vaccines/immunology , Simian Acquired Immunodeficiency Syndrome/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL